Skip to main content
. 2020 Aug 24;21(5):1175–1181. doi: 10.5811/westjem.2020.6.46452

Table 2.

Assessment scores and buprenorphine dose administered.

Buprenorphine 4 mg Buprenorphine 8 mg No buprenorphine
SOWS
 Initial SOWS (N = 18)
  <10 (N = 0) - - -
  10 or above (N = 18) 1/18 (5.6%) 17/18 (94.4%) -
 2nd SOWS (N = 16)
  <10 (N = 8) - - 8/8 (100%)
  10 or above (N = 5) 5/5 (100%) - -
  No repeat score (N = 3) 3/3 (100%) - -
COWS
 Initial COWS (N = 43)
  <8 (N = 2) 1/2 (50%) 1/2 (50%) -
  8 or above (N = 39) 1/39 (2.6%) 38/39 (97.4%) -
  No initial score (N = 2) - 2/2 (100%) -
 2nd COWS (N = 31)
  <8 (N = 12) 1/12 (8.3%) 1/12 (8.3%) 10/12 (83.3%)
  8 or above (N = 15) 11/15 (73.3%) 2/15 (13.3%) 2/15 (13.3%)
  No repeat score (N = 4) 2/4 (50%) 2/4 (50%) -
Clinical judgment (or some other)
 1st dose given (N = 16) 3/16 (18.75%) 13/16 (81.25%) -
 2nd dose given (N = 4) 2/4 (50%) 2/4 (50%) -

mg, milligram; SOWS, short opiate withdrawal scale; COWS, Clinical Opiate Withdrawal Scale.